Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill caps insulin costs for people age 26 and younger who have private health insurance, effective January 1, 2026. Young people would pay no more than $35 per 30-day supply of insulin, or 25 percent of the negotiated price—whichever is lower—with no deductible required. The law applies to both employer-sponsored and individual health plans, and requires insurers to cover at least one form of each type of insulin (such as rapid-acting, long-acting, or premixed varieties) in different delivery methods like vials or pumps. These insulin cost-sharing payments would count toward annual deductibles and out-of-pocket maximums as normal. The legislation doesn't require coverage of non-preferred insulin products or affect cost-sharing for people older than 26, and regulations will be developed by the Departments of Health and Human Services, Labor, and Treasury.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.